- Home
- BZUN vs SLRN Comparison
BZUN vs SLRN Comparison
Compare BZUN & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- SLRN
- Stock Information
- Founded
- BZUN 2007
- SLRN 2020
- Country
- BZUN China
- SLRN United States
- Employees
- BZUN N/A
- SLRN N/A
- Industry
- BZUN Catalog/Specialty Distribution
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- BZUN Consumer Discretionary
- SLRN Health Care
- Exchange
- BZUN Nasdaq
- SLRN Nasdaq
- Market Cap
- BZUN 188.7M
- SLRN 197.6M
- IPO Year
- BZUN N/A
- SLRN 2023
- Fundamental
- Price
- BZUN $3.73
- SLRN $2.60
- Analyst Decision
- BZUN Buy
- SLRN Hold
- Analyst Count
- BZUN 2
- SLRN 5
- Target Price
- BZUN $3.20
- SLRN $9.60
- AVG Volume (30 Days)
- BZUN 532.4K
- SLRN 3.2M
- Earning Date
- BZUN 03-20-2025
- SLRN 03-27-2025
- Dividend Yield
- BZUN N/A
- SLRN N/A
- EPS Growth
- BZUN N/A
- SLRN N/A
- EPS
- BZUN N/A
- SLRN N/A
- Revenue
- BZUN $1,312,737,613.00
- SLRN N/A
- Revenue This Year
- BZUN $8.16
- SLRN N/A
- Revenue Next Year
- BZUN $4.71
- SLRN N/A
- P/E Ratio
- BZUN N/A
- SLRN N/A
- Revenue Growth
- BZUN 7.26
- SLRN N/A
- 52 Week Low
- BZUN $2.11
- SLRN $1.85
- 52 Week High
- BZUN $4.38
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- BZUN 63.06
- SLRN 63.62
- Support Level
- BZUN $3.51
- SLRN $2.08
- Resistance Level
- BZUN $3.97
- SLRN $2.18
- Average True Range (ATR)
- BZUN 0.21
- SLRN 0.13
- MACD
- BZUN 0.02
- SLRN 0.11
- Stochastic Oscillator
- BZUN 73.91
- SLRN 94.97
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.